A carregar...
Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas
BACKGROUND: Thymomas are rare malignancies. Thymectomy is the optimal therapy which could prolong the survival of patients. However, prognostic factors of thymomas are not clear. METHODS: Thymomas patients were enrolled from 2001 to 2016. Clinical and pathological prognostic factors of thymomas were...
Na minha lista:
| Publicado no: | Gland Surg |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225485/ https://ncbi.nlm.nih.gov/pubmed/32420253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs.2020.03.01 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|